Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 315.00
Bid: 311.50
Ask: 318.00
Change: 0.00 (0.00%)
Spread: 6.50 (2.087%)
Open: 315.00
High: 315.00
Low: 315.00
Prev. Close: 315.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 as investors look to Fed rate decision

Mon, 29th Apr 2024 16:58

(Alliance News) - The FTSE 100 in London closed higher on Monday, outperforming its European counterparts, as investors eye this week's interest rate decision from the US Federal Reserve.

The FTSE 100 index closed up 7.20 points, 0.1%, at 8,147.03. The FTSE 250 ended up 260.63 points, 1.3%, at 20,084.79, and the AIM All-Share closed up 8.05 points, 1.1%, at 763.33.

The Cboe UK 100 ended up 0.1% at 814.08, the Cboe UK 250 closed up 1.2% at 17,335.92, and the Cboe Small Companies ended up 0.3% at 15,709.26.

In European equities on Monday, the CAC 40 in Paris was down 0.3% and the DAX 40 in Frankfurt closed down 0.2%.

On Monday, the FTSE 100 climbed to 8,189.14, its best-ever level, before falling after midday. In the year-to-date, the index is up 5.5%.

The Federal Reserve announces an interest rate decision on Wednesday. It is expected to leave rates unmoved, but with recent inflation readings coming in hot, and words from policymakers hawkish, focus will be on what Chair Jerome Powell has to say.

"Fed easing expectations have been pushed out. Odds of a June cut have fallen to around 10%, while July odds have fallen to 35% and September odds have fallen below 80%. A November cut is fully priced in, but the odds have fallen below 100% from time to time," analysts at Brown Brothers Harriman said.

US inflation pressure was hotter than expected last month, according to the Federal Reserve's preferred gauge released Friday.

The Bureau of Economic Analysis said the core personal consumption index gauge grew 2.8% in March, the annual pace of growth unmoved from February. In February, it had cooled slightly from 2.9% in January.

Stocks in New York were higher at the London equities close, with the DJIA, the S&P 500 index, and the Nasdaq Composite were all up 0.2%.

The pound was quoted at USD1.2554 at the London equities close Monday, higher compared to USD1.2453 at the close on Friday. The euro stood at USD1.0717 at the European equities close Monday, up against USD1.0676 at the same time on Friday.

However, against the yen, the dollar was trading at JPY156.64, lower compared to JPY157.41 late Friday.

In the FTSE 100, miner Anglo American added 3.8% amid growing conviction that it could receive another takeover bid.

Reuters reported BHP is mulling an improved bid for Anglo American. Citing a source, the news agency reported a sweetened offer could be made "in coming weeks". BHP last week Thursday confirmed it had offered to buy Anglo American in an all-share deal valuing the mining group at GBP31.1 billion. Anglo American rejected the offer.

"Investors have clearly spent the weekend sitting down with a cuppa and reading the papers as all the column inches about potential counter bids for Anglo American have got people reaching for the 'buy' button in their ISA or pension," said AJ Bell's Russ Mould.

Entain rose 2.1%, after it announced the repricing of two existing Term B loans, which it said will improve liquidity by about GBP295 million.

The Isle of Man-based bookmaker, which owns Ladbrokes and Coral, said the changes applied to a USD term loan worth USD1.74 billion, and a EUR term loan worth EUR1.03 billion.

In the FTSE 250, Playtech surged 12%.

The Isle of Man-based gambling software development company announced the expansion of its iPoker network into the Czech Republic, in partnership with Fortuna Entertainment Group.

"This launch represents a significant milestone for both Playtech and Fortuna, as it introduces poker into the Fortuna Entertainment Group for the first time. Through Playtech's iPoker network, Fortuna's players in the Czech Republic will now have access to a diverse range of poker games, benefitting from a strong international liquidity pool of players from all around the world, plus a high-quality player experience and state-of-the-art poker product," Playtech said.

Amongst London's small-caps, Oxford BioMedica shot up 10%.

The gene and cell-therapy company said it is seeing decent demand for its contract development and manufacturing organisation offering, as it moves away from the Covid-19 vaccine era.

Brent oil was quoted at USD87.27 a barrel at the London equities close Monday, down from USD88.26 late Friday.

Gold was quoted at USD2,337.40 an ounce at the London equities close Monday, higher against USD2,333.37 at the close on Friday.

In Tuesday's UK corporate calendar, there are first quarter results from HSBC, as well as full year results from Whitbread. There are trading statements from Coca-Cola HBC, Glencore, and Hargreaves Lansdown.

The economic calendar for Tuesday has a eurozone gross domestic product reading, as well as consumer price inflation data. There is unemployment data from Germany, alongside retail sales data.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
1 Aug 2022 14:30

EXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO role

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

Read more
26 Jul 2022 11:12

SMALL-CAP WINNERS & LOSERS: Reach and Wickes sink on dark outlook

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

Read more
26 Jul 2022 11:09

Oxford BioMedica begins new project and signs license agreement

(Alliance News) - Oxford BioMedica PLC on Tuesday said it started a new project and signed a license and supply agreement.

Read more
26 Jul 2022 08:44

Oxford Biomedica inks LSA with US biotech firm, launches new project with Orchard Therapeutics

(Sharecast News) - Gene and cell therapy group Oxford Biomedica inked a new licence and supply agreement with an unnamed US private biotechnology on Tuesday company and also launched a new project with Orchard Therapeutics.

Read more
22 Jul 2022 10:36

SMALL-CAP WINNERS & LOSERS: Made.com and Hochschild slide again

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

Read more
21 Jul 2022 11:13

IN BRIEF: Oxford BioMedica shares up on deal expansion in CAR-T

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Expands its license and clinical supply agreement with Juno Therapeutics Inc, subsidiary of New-York based pharmaceutical industry company Bristol Myers Squibb. It says the expansion relates to the start of two new viral vector programmes for CAR-T therapies. "Oxford Biomedica will receive an undisclosed target nomination fee and potential payments upon the achievement of certain milestones," it notes.

Read more
21 Jul 2022 10:28

SMALL-CAP WINNERS & LOSERS: Go-Ahead suitor pulls out; Costain rises

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

Read more
1 Jul 2022 10:41

SMALL-CAP WINNERS & LOSERS: Oxford BioMedica rises on AstraZeneca deal

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

Read more
1 Jul 2022 08:56

LONDON MARKET OPEN: Recession fear hits stocks; Oxford Biomedica rises

(Alliance News) - Stocks in London opened lower on Friday as investors continued to fret over prospects of a recession as central banks raise interest rates.

Read more
1 Jul 2022 08:31

Oxford BioMedica signs new Covid-19 vaccine deal with AstraZeneca

(Alliance News) - Oxford BioMedica PLC on Friday said it has signed a new three year agreement with AstraZeneca PLC, which will facilitate potential future manufacturing opportunities for the FTSE 100-listed drugmaker's Covid-19 vaccine.

Read more
1 Jul 2022 08:07

LONDON BRIEFING: Oxford Biomedica signs new Covid jab deal with Astra

(Alliance News) - Oxford Biomedica on Friday said that it has signed a new three-year agreement with AstraZeneca, which would facilitate potential future manufacturing opportunities for the FTSE 100-listed drugmaker's Covid-19 vaccine.

Read more
1 Jul 2022 07:48

LONDON MARKET PRE-OPEN: Oxford Biomedica inks new AstraZeneca jab deal

(Alliance News) - Stock prices in London are seen opening lower on Friday following another sell-off on Wall Street fuelled by recession fears, while focus will be on a slew of manufacturing PMI readings later in the day.

Read more
1 Jul 2022 07:03

Oxford Biomedica signs new Covid vaccine deal with AstraZeneca

(Sharecast News) - Oxford Biomedica has signed a new three-year deal to make AstraZeneca's Covid-19 vaccine beyond this year when the original agreement expires, the company said on Friday.

Read more
14 Jun 2022 11:16

US FDA lifts clinical hold on Oxford BioMedica partner's trial

(Alliance News) - Oxford BioMedica PLC on Tuesday noted that the US Food & Drug Administration lifted the clinical hold on Homology Medicines Inc's pheNIX gene therapy trial.

Read more
14 Jun 2022 09:35

Oxford Biomedica sees FDA lift clinical hold on Homology's HMI-102 trial

(Sharecast News) - Gene and cell therapy group Oxford Biomedica said on Tuesday that the US Food and Drug Administration had notified Homology Medicines that the clinical hold on its pheNIX gene therapy trial of HMI-102 in adults with phenylketonuria had been lifted.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.